Now is the time for the FDA to modernize its blood donation policy. In particular, the FDA should adopt an individual-based risk assessment (IRA) that applies to all potential donors.

The recommendations, first proposed in January, ask that all donors answer individual risk assessment questions to screen for possible HIV exposure.

Myriad Genetics' RiskScore improves breast cancer screening recommendations based on individual risk assessments, as shown in a recent study. Quiver AI Summary Myriad Genetics, Inc. announced in a ...